Patents by Inventor David Kay
David Kay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10979290Abstract: The subject disclosure relates to techniques for monitoring contextual and performance information of a device for anticipatorily sending update information to the device. An interface component can receive, from the client, contextual information indicating an operating environment of the client and performance information that is associated with one or more operations being performed by the client based on the operating environment, and send, based on correlation information, update information to the client. Further, a service component can to infer a relationship between the contextual information and the performance information to obtain the correlation information. In other embodiments, a client can populate a cache with portion(s) of the contextual information to obtain cached information, and send at least a portion of the cached information to a system including one or more aspects of the service component.Type: GrantFiled: December 19, 2016Date of Patent: April 13, 2021Assignee: Microsoft Technology Licensing, LLCInventors: Edward Reus, Mario Goertzel, Scott Field, Michael Joseph Healy, Joseph Dadzie, David Kays, John Douceur, Henricus Johannes Maria Meijer
-
Patent number: 10961232Abstract: The present invention relates to pyrazine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: wherein the variables are as defined herein.Type: GrantFiled: May 30, 2017Date of Patent: March 30, 2021Assignee: VERTEX PHARMACEUTICALS INCORPORATEDInventors: Jean-Damien Charrier, Steven Durrant, David Kay, Ronald Knegtel, Somhairle MacCormick, Michael Mortimore, Michael O'Donnell, Joanne Pinder, Alistair Rutherford, Anisa Nizarali Virani, Stephen Young, Philip Michael Reaper
-
Publication number: 20210080735Abstract: A head up display arrangement is for a motor vehicle having a human occupant. A light source emits a light field. An infrared camera detects infrared energy. A combiner is positioned and configured to reflect the light field such that the light field can be viewed by the human occupant as a virtual image. The combiner has a region configured to reflect infra-red energy emitted by a face of the occupant such that the infrared energy is received by the infrared camera.Type: ApplicationFiled: December 2, 2020Publication date: March 18, 2021Inventors: DAVID KAY LAMBERT, WALTER JOSEPH NILL
-
Publication number: 20210047333Abstract: The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: or a pharmaceutically acceptable salt, wherein the variables are as devined herein. Moreover, The compounds of this invention have formula I-A: or a pharmaceutically acceptable salt, wherein the variables are as defined herein.Type: ApplicationFiled: August 31, 2020Publication date: February 18, 2021Inventors: Nadia AHMAD, Dean BOYALL, Jean-Damien CHARRIER, Chris DAVIS, Rebecca DAVIS, Steven DURRANT, Gorka ETXEBARRIA I JARDI, Damien FRAYSSE, Juan-Miguel JIMENEZ, David KAY, Ronald KNEGTEL, Donald MIDDLETON, Michael O'DONNELL, Maninder PANESAR, Francoise PIERARD, Marie, Joanne PINDER, David SHAW, Pierre-Henri STORCK, John STUDLEY, Heather TWIN
-
Patent number: 10884249Abstract: A head up display arrangement is for a motor vehicle having a human occupant. A light source emits a light field. An infrared camera detects infrared energy. A combiner is positioned and configured to reflect the light field such that the light field can be viewed by the human occupant as a virtual image. The combiner has a region configured to reflect infra-red energy emitted by a face of the occupant such that the infrared energy is received by the infrared camera.Type: GrantFiled: October 16, 2019Date of Patent: January 5, 2021Assignee: Panasonic Automotive Systems Company of America, Division of Panasonic Corporation of North AmericaInventors: David Kay Lambert, Walter Joseph Nill
-
Publication number: 20200388079Abstract: A head up display arrangement for a motor vehicle includes a source of a first video signal. A driver monitor system detects a location of at least a portion of a human driver of the motor vehicle. An electronic processor is communicatively coupled to the first video signal source and to the driver monitor system. The electronic processor produces a second video signal that is dependent upon the first video signal and that includes parallax information. The parallax information is based on the detected location of the portion of the driver. A head up display projection device produces a virtual image that is visible to the driver and that is based upon the second video signal.Type: ApplicationFiled: July 10, 2020Publication date: December 10, 2020Inventors: DAVID KAY LAMBERT, DEREK LOUIS DIDIER
-
Publication number: 20200360752Abstract: A fluid distribution system includes a water line configured to receive water from a water source, an agent line configured to receive agent from an agent source, a flush line configured to receive the water from the water source and connecting to the agent line at a junction, a flush valve positioned to selectively prevent the water from flowing along the flush line, an agent valve positioned to selectively prevent the agent from flowing along the agent line, a first flow meter positioned along the agent line downstream of the junction, a second flow meter positioned downstream of the first flow meter, an eductor coupled to the agent line and the water line downstream of the first flow meter and upstream of the second flow meter, a metering valve positioned downstream of the first flow meter and upstream of the eductor, and a controller.Type: ApplicationFiled: July 31, 2020Publication date: November 19, 2020Applicant: Oshkosh CorporationInventors: Jason Shively, Tim Nelson, David Kay, Seth Newlin
-
Patent number: 10787452Abstract: The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: or a pharmaceutically acceptable salt, wherein the variables are as devined herein. Moreover, The compounds of this invention have formula I-A: or a pharmaceutically acceptable salt, wherein the variables are as defined herein.Type: GrantFiled: April 25, 2017Date of Patent: September 29, 2020Assignee: VERTEX PHARMACEUTICALS INCORPORATEDInventors: Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis, Steven Durrant, Gorka Etxebarria I Jardi, Damien Fraysse, Juan-Miguel Jimenez, David Kay, Ronald Knegtel, Donald Middleton, Michael O'Donnell, Maninder Panesar, Francoise Pierard, Joanne Pinder, David Shaw, Pierre-Henri Storck, John Studley, Heather Twin
-
Patent number: 10758759Abstract: An agent distribution system includes a water tank, a flush line, a flush valve, an agent storage tank, an agent line, an agent valve, a first flow meter, and a second flow meter. The flush line receives water from the water tank. The flush valve is configured to selectively prevent water from flowing along the flush line downstream of the flush valve. The agent line receives agent from the agent tank. The agent valve is configured to selectively prevent agent from flowing along the agent line downstream of the agent valve. The flush line extends into the agent line at a junction. The junction is disposed downstream of the agent valve. The first flow meter is positioned along the agent line downstream of the junction. The second flow meter is positioned downstream of the first flow meter and upstream of a discharge system.Type: GrantFiled: February 7, 2018Date of Patent: September 1, 2020Assignee: Oshkosh CorporationInventors: Jason Shively, Tim Nelson, David Kay, Seth Newlin
-
Patent number: 10732420Abstract: A motor vehicle includes a head up display projector producing a light field based upon image data such that the light field is reflected off of a windshield of the motor vehicle and is then visible to a driver of the motor vehicle as a virtual image. First means determines locations of physical objects visible to the driver through the windshield. Second means determines locations of eyes of the driver. An electronic processor receives first data indicative of the determined locations of the physical objects, and receives second data indicative of the determined locations of the eyes of the driver. The electronic processor produces the image data dependent upon the first data and the second data such that a symbol in the virtual image appears to be in a predetermined position relative to a selected one of the physical objects.Type: GrantFiled: September 18, 2017Date of Patent: August 4, 2020Assignee: Panasonic Automotive Systems Company of America, Division of Panasonic Corporation of North AmericaInventors: David Kay Lambert, Walter Joseph Nill
-
Patent number: 10671813Abstract: Systems and methods are described herein for performing actions based on a determined intent within messages received by a mobile device. In some embodiments, the systems and methods may access a message received by a mobile application (e.g., text messaging application, chat application, and so on) of the mobile device, analyze the message to determine an intent of the message (e.g., whether the message includes a request or a task for a recipient of the message), and perform an action based on the determined intent (e.g., set a reminder when the message includes a task for the recipient). Further details are described herein.Type: GrantFiled: May 27, 2016Date of Patent: June 2, 2020Assignee: NUANCE COMMUNICATIONS, INC.Inventors: Donni McCray, Brian Yee, David Kay, Aaron Sheedy
-
Publication number: 20200140441Abstract: The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: or a pharmaceutically acceptable salt, wherein the variables are as devined herein. Moreover, The compounds of this invention have formula I-A: or a pharmaceutically acceptable salt, wherein the variables are as defined herein.Type: ApplicationFiled: August 6, 2019Publication date: May 7, 2020Inventors: Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis, Steven Durrant, Gorka Etxebarria I Jardi, Damien Fraysse, Juan-Miguel Jimenez, David Kay, Ronald Knegtel, Donald Middleton, Michael O'Donnell, Maninder Panesar, Francoise Pierard, Joanne Pinder, David Shaw, Pierre-Henri Storck, John Studley, Heather Twin
-
Publication number: 20200124862Abstract: A head up display arrangement is for a motor vehicle having a human occupant. A light source emits a light field. An infrared camera detects infrared energy. A combiner is positioned and configured to reflect the light field such that the light field can be viewed by the human occupant as a virtual image. The combiner has a region configured to reflect infra-red energy emitted by a face of the occupant such that the infrared energy is received by the infrared camera.Type: ApplicationFiled: October 16, 2019Publication date: April 23, 2020Inventors: DAVID KAY LAMBERT, WALTER JOSEPH NILL
-
Patent number: 10607468Abstract: A communication apparatus includes a controller. The controller is configured to: receive a message, such as a communication request; determine a type for said message; select a first recipient layer based on said type, said first recipient layer comprising at least one recipient; transmit said message to at least one of said at least one recipient of said first recipient layer; receive a confirmation from said at least one of said at least one recipient of said first recipient layer; and in response thereto transmit said confirmation from said at least one of said at least one recipient of said first recipient layer to at least another one of said at least one recipient of said first recipient layer.Type: GrantFiled: December 21, 2018Date of Patent: March 31, 2020Assignee: Doro ABInventors: Peter Cullin, Jérôme Arnaud, Acher Criou, Fredrik Palmqvist, David Kay, Xavier Corbin, Fredrik Jacobsson, Peter Johansson, Alf Ingvarsson
-
Publication number: 20190391388Abstract: A head up display arrangement for a motor vehicle includes a head up display module having a picture generation unit emitting a light field. A plurality of linear polarizers are arranged in a stack. A first of the linear polarizers receives the light field from the picture generation unit. A last of the linear polarizers emits the light field. A windshield reflects the light field from the last linear polarizer such that the reflected light field is visible to a human driver of the motor vehicle as a virtual image.Type: ApplicationFiled: June 19, 2019Publication date: December 26, 2019Inventors: DAVID KAY LAMBERT, STEVEN CRAIG BOWER
-
Patent number: 10479784Abstract: The present invention relates to pyrazine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: wherein the variables are as defined herein.Type: GrantFiled: April 30, 2018Date of Patent: November 19, 2019Assignee: VERTEX PHARMACEUTICALS INCORPORATEDInventors: Jean-Damien Charrier, Steven John Durrant, David Kay, Ronald Marcellus Alphonsus Knegtel, Somhairle MacCormick, Michael Paul Mortimore, Michael Edward O'Donnell, Joanne Pinder, Alistair Rutherford, Anisa Nizarali Virani, Stephen Clinton Young, Philip Michael Reaper
-
Patent number: 10435026Abstract: A vehicle includes a chassis, a driveline and an accessory coupled to the chassis and configured to receive rotational mechanical energy, a first driver and a second driver coupled to the chassis and configured to provide rotational mechanical energy, and a power transmission device. The power transmission device includes a housing coupled to the chassis, a first input shaft configured to receive the rotational mechanical energy from the first driver, a second input shaft configured to receive the rotational mechanical energy from the second driver, a primary output interface coupled to the driveline, a power takeoff shaft radially aligned with the first input shaft and coupled to the accessory, a first clutch configured to selectively rotationally couple the first input shaft to the primary output interface, and a second clutch configured to selectively rotationally couple the first input shaft to the power takeoff shaft.Type: GrantFiled: February 7, 2018Date of Patent: October 8, 2019Assignee: Oshkosh CorporationInventors: Jason Shively, Martin Schimke, Andrew Kotloski, Seth Newlin, David Kay, Chad Hartfiel
-
Patent number: 10416447Abstract: A head up display arrangement for a motor vehicle includes a head up display projector including a lens with a polarizer. The head up display projector emits a linearly polarized light field via the lens. A windshield reflects the light field such that the reflected light field is visible to a human driver of the motor vehicle as a virtual image. The windshield includes an outer plastic layer sandwiched between a half-wave plate and an outer glass layer. An inner plastic layer is sandwiched between the half-wave plate and an inner glass layer.Type: GrantFiled: October 12, 2017Date of Patent: September 17, 2019Assignee: Panasonic Automotive Systems Company of America, Division of Panasonic Corporation of North AmericaInventors: David Kay Lambert, Walter Joseph Nill
-
Publication number: 20190262643Abstract: A fire-fighting vehicle includes a boom assembly movably coupled to a chassis, a penetrating nozzle coupled to the boom assembly, an actuator that moves the penetrating nozzle relative to the chassis, and a controller operatively coupled to a sensor. The penetrating nozzle includes a piercing tip and an outlet configured to be selectively fluidly coupled to a supply of fire suppressant. The piercing tip is repositionable relative to a surface of an object having an interior cavity. The outlet supplies fire suppressant into the interior cavity when the piercing tip is within the interior cavity. The sensor provides data relating to at least one of a position and an orientation of the piercing tip relative to the surface. The controller determines an angular orientation of the piercing tip relative to the surface based on the data.Type: ApplicationFiled: May 10, 2019Publication date: August 29, 2019Applicant: Oshkosh CorporationInventors: Jason Shively, David Kay, Noah Kuntz, Tim Nelson
-
Patent number: 10392391Abstract: The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I: or a pharmaceutically acceptable salt, wherein the variables are as devined herein. Moreover, The compounds of this invention have formula I-A: or a pharmaceutically acceptable salt, wherein the variables are as defined herein.Type: GrantFiled: June 26, 2017Date of Patent: August 27, 2019Assignee: Vertex Pharmaceuticals IncorporatedInventors: Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis, Steven Durrant, Gorka Etxebarria I Jardi, Damien Fraysse, Juan-Miguel Jimenez, David Kay, Ronald Knegtel, Donald Middleton, Michael O'Donnell, Maninder Panesar, Francoise Pierard, Joanne Pinder, David Shaw, Pierre-Henri Storck, John Studley, Heather Twin